Atlas Lithium (ATLX) Q3 2026 earnings summary

Executive summary

• Neves advanced toward production with project contracts secured and modular processing-plant pre-assembly underway; target capacity is ~146,000 tonnes of lithium concentrate annually.

• Q3 net loss widened to $10.3M from $8.0M YoY; nine-month net loss reached $38.3M versus $24.5M.

Financial highlights

• Q3 2026 net loss was $10.3M; net loss attributable to common stockholders was $8.0M versus $7.0M in Q3 2025.

• 9M 2026 net loss was $38.3M versus $24.5M; loss attributable to common stockholders was $31.8M versus $21.5M.

• Basic and diluted loss per share improved to $0.27 in Q3 from $0.35; 9M loss per share improved to $1.10 from $1.18.

• 9M G&A expense increased ~$12.5M YoY, mainly from payroll and third-party services; exploration expense rose ~$1.5M, including Malacacheta Graphite Project activity.

Outlook and guidance

• Neves remained on track toward first commercial production; planned annual concentrate capacity is ~146,000 tonnes under the definitive feasibility study.

• Cash and equivalents were expected to cover working capital and capital expenditure needs for at least 12 months from the financial-statement date.

• Outstanding convertible notes mature in November 2026; repayment of principal and accrued interest was expected from available cash.